Tokyo Tape
Sign in
← Astena Holdings

Quarterly report · Q3

8095.TEDINET S100PC1Z
Period2021-12-01 → 2022-08-31
Filed2022-10-12
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 35
MetricValuePeriodScopeSource row
Revenue¥36.9bn2021-12-01 → 2022-08-31Cons.Net sales
Revenue¥72.3bn2020-12-01 → 2021-11-30Cons.Net sales (5-year summary)
Revenue¥53.7bn2020-12-01 → 2021-08-31Cons.Net sales
Operating income¥426m2021-12-01 → 2022-08-31Cons.Operating income
Operating income¥2.0bn2020-12-01 → 2021-08-31Cons.Operating income
Ordinary income¥517m2021-12-01 → 2022-08-31Cons.Ordinary income
Ordinary income¥2.4bn2020-12-01 → 2021-11-30Cons.Ordinary income loss (5-year summary)
Ordinary income¥2.0bn2020-12-01 → 2021-08-31Cons.Ordinary income
Profit before tax¥1.1bn2021-12-01 → 2022-08-31Cons.Income before income taxes
Profit before tax¥2.0bn2020-12-01 → 2021-08-31Cons.Income before income taxes
Net income (owners)¥606m2021-12-01 → 2022-08-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥1.7bn2020-12-01 → 2021-11-30Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥1.1bn2020-12-01 → 2021-08-31Cons.Profit loss attributable to owners of parent
Net income¥601m2021-12-01 → 2022-08-31Cons.Profit loss
Net income¥1.1bn2020-12-01 → 2021-08-31Cons.Profit loss
Total assets¥62.9bnat 2022-08-31Cons.Assets
Total assets¥63.6bnat 2021-11-30Cons.Assets
Total assets¥62.0bnat 2021-08-31Cons.Total assets (5-year summary)
Total liabilities¥35.7bnat 2022-08-31Cons.Liabilities
Total liabilities¥36.5bnat 2021-11-30Cons.Liabilities
Net assets / equity¥27.1bnat 2022-08-31Cons.Net assets
Net assets / equity¥27.0bnat 2021-11-30Cons.Net assets
Net assets / equity¥26.5bnat 2021-08-31Cons.Net assets (5-year summary)
Cash and deposits¥7.2bnat 2022-08-31Cons.Cash and deposits
Cash and deposits¥10.9bnat 2021-11-30Cons.Cash and deposits
EPS (basic)¥15.172021-12-01 → 2022-08-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-8.192022-06-01 → 2022-08-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥46.862020-12-01 → 2021-11-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥31.22020-12-01 → 2021-08-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥3.942021-06-01 → 2021-08-31dCons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥46.632020-12-01 → 2021-11-30Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥30.992020-12-01 → 2021-08-31Cons.Diluted earnings per share (5-year summary)
Equity ratio43.0%at 2022-08-31Cons.Equity to asset ratio (5-year summary)
Equity ratio42.5%at 2021-11-30Cons.Equity to asset ratio (5-year summary)
Equity ratio42.8%at 2021-08-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 58
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2021-12-01 → 2022-08-31¥1m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2021-12-01 → 2022-08-31¥1m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2021-12-01 → 2022-08-31−¥29m
Reconciling Itemsreconcilingrevenue2021-12-01 → 2022-08-31−¥944m
Reconciling Itemsreconcilingrevenue intersegment2021-12-01 → 2022-08-31−¥944m
Reconciling Itemsreconcilingsegment profit2021-12-01 → 2022-08-31¥119m
jpcrp040300-q3r_E02585-000Fine Chemicalsreportable segmentrevenue2021-12-01 → 2022-08-31¥11.5bn
jpcrp040300-q3r_E02585-000Fine Chemicalsreportable segmentrevenue external2021-12-01 → 2022-08-31¥11.1bn
jpcrp040300-q3r_E02585-000Fine Chemicalsreportable segmentrevenue intersegment2021-12-01 → 2022-08-31¥438m
jpcrp040300-q3r_E02585-000Fine Chemicalsreportable segmentsegment profit2021-12-01 → 2022-08-31¥169m
jpcrp040300-q3r_E02585-000Health And Beauty Care Foodreportable segmentrevenue2021-12-01 → 2022-08-31¥10.5bn
jpcrp040300-q3r_E02585-000Health And Beauty Care Foodreportable segmentrevenue external2021-12-01 → 2022-08-31¥10.4bn
jpcrp040300-q3r_E02585-000Health And Beauty Care Foodreportable segmentrevenue intersegment2021-12-01 → 2022-08-31¥105m
jpcrp040300-q3r_E02585-000Health And Beauty Care Foodreportable segmentsegment profit2021-12-01 → 2022-08-31−¥92m
jpcrp040300-q3r_E02585-000Industrial Chemicalsreportable segmentrevenue2021-12-01 → 2022-08-31¥6.5bn
jpcrp040300-q3r_E02585-000Industrial Chemicalsreportable segmentrevenue external2021-12-01 → 2022-08-31¥6.5bn
jpcrp040300-q3r_E02585-000Industrial Chemicalsreportable segmentrevenue intersegment2021-12-01 → 2022-08-31¥70m
jpcrp040300-q3r_E02585-000Industrial Chemicalsreportable segmentsegment profit2021-12-01 → 2022-08-31−¥130m
jpcrp040300-q3r_E02585-000Medicalreportable segmentrevenue2021-12-01 → 2022-08-31¥9.3bn
jpcrp040300-q3r_E02585-000Medicalreportable segmentrevenue external2021-12-01 → 2022-08-31¥8.9bn
jpcrp040300-q3r_E02585-000Medicalreportable segmentrevenue intersegment2021-12-01 → 2022-08-31¥331m
jpcrp040300-q3r_E02585-000Medicalreportable segmentsegment profit2021-12-01 → 2022-08-31¥389m
—segment totalrevenue2021-12-01 → 2022-08-31¥37.9bn
—segment totalrevenue external2021-12-01 → 2022-08-31¥36.9bn
—segment totalrevenue intersegment2021-12-01 → 2022-08-31¥944m
—segment totalsegment profit2021-12-01 → 2022-08-31¥336m
Total Of Reportable Segments And Otherssegment totalrevenue2021-12-01 → 2022-08-31¥37.9bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-12-01 → 2022-08-31¥36.9bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2021-12-01 → 2022-08-31¥944m
Total Of Reportable Segments And Otherssegment totalsegment profit2021-12-01 → 2022-08-31¥307m
Reconciling Itemsreconcilingrevenue2020-12-01 → 2021-08-31−¥975m
Reconciling Itemsreconcilingrevenue external2020-12-01 → 2021-08-31¥36,000
Reconciling Itemsreconcilingrevenue intersegment2020-12-01 → 2021-08-31−¥975m
Reconciling Itemsreconcilingsegment profit2020-12-01 → 2021-08-31−¥48m
jpcrp040300-q3r_E02585-000Fine Chemicalsreportable segmentrevenue2020-12-01 → 2021-08-31¥17.6bn
jpcrp040300-q3r_E02585-000Fine Chemicalsreportable segmentrevenue external2020-12-01 → 2021-08-31¥17.0bn
jpcrp040300-q3r_E02585-000Fine Chemicalsreportable segmentrevenue intersegment2020-12-01 → 2021-08-31¥669m
jpcrp040300-q3r_E02585-000Fine Chemicalsreportable segmentsegment profit2020-12-01 → 2021-08-31¥1.0bn
jpcrp040300-q3r_E02585-000Health And Beauty Care Foodreportable segmentrevenue2020-12-01 → 2021-08-31¥20.9bn
jpcrp040300-q3r_E02585-000Health And Beauty Care Foodreportable segmentrevenue external2020-12-01 → 2021-08-31¥20.8bn
jpcrp040300-q3r_E02585-000Health And Beauty Care Foodreportable segmentrevenue intersegment2020-12-01 → 2021-08-31¥29m
jpcrp040300-q3r_E02585-000Health And Beauty Care Foodreportable segmentsegment profit2020-12-01 → 2021-08-31−¥442m
jpcrp040300-q3r_E02585-000Industrial Chemicalsreportable segmentrevenue2020-12-01 → 2021-08-31¥6.3bn
jpcrp040300-q3r_E02585-000Industrial Chemicalsreportable segmentrevenue external2020-12-01 → 2021-08-31¥6.2bn
jpcrp040300-q3r_E02585-000Industrial Chemicalsreportable segmentrevenue intersegment2020-12-01 → 2021-08-31¥45m
jpcrp040300-q3r_E02585-000Industrial Chemicalsreportable segmentsegment profit2020-12-01 → 2021-08-31¥311m
jpcrp040300-q3r_E02585-000Medicalreportable segmentrevenue2020-12-01 → 2021-08-31¥9.9bn
jpcrp040300-q3r_E02585-000Medicalreportable segmentrevenue external2020-12-01 → 2021-08-31¥9.7bn
jpcrp040300-q3r_E02585-000Medicalreportable segmentrevenue intersegment2020-12-01 → 2021-08-31¥232m
jpcrp040300-q3r_E02585-000Medicalreportable segmentsegment profit2020-12-01 → 2021-08-31¥1.1bn
—segment totalrevenue2020-12-01 → 2021-08-31¥54.7bn
—segment totalrevenue external2020-12-01 → 2021-08-31¥53.7bn
—segment totalrevenue intersegment2020-12-01 → 2021-08-31¥975m
—segment totalsegment profit2020-12-01 → 2021-08-31¥2.0bn
Total Of Reportable Segments And Otherssegment totalrevenue2020-12-01 → 2021-08-31¥54.7bn
Total Of Reportable Segments And Otherssegment totalrevenue external2020-12-01 → 2021-08-31¥53.7bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2020-12-01 → 2021-08-31¥975m
Total Of Reportable Segments And Otherssegment totalsegment profit2020-12-01 → 2021-08-31¥2.0bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 452
ItemContextValueUnit
Income taxes deferredPrior1YTDDuration81374000JPY
Income taxes deferredCurrentYTDDuration-420519000JPY
Income taxesPrior1YTDDuration853579000JPY
Income taxesCurrentYTDDuration523724000JPY
Profit lossPrior1YTDDuration1130234000JPY
Profit lossCurrentYTDDuration601017000JPY
Profit loss attributable to non controlling interestsPrior1YTDDuration－JPY
Profit loss attributable to non controlling interestsCurrentYTDDuration-5033000JPY
Profit loss attributable to owners of parentPrior1YTDDuration1130234000JPY
Profit loss attributable to owners of parentCurrentYTDDuration606050000JPY
Profit lossPrior1YTDDuration1130234000JPY
Profit lossCurrentYTDDuration601017000JPY
Valuation difference on available for sale securities net of tax ociPrior1YTDDuration137477000JPY
Valuation difference on available for sale securities net of tax ociCurrentYTDDuration65905000JPY
Deferred gains or losses on hedges net of tax ociPrior1YTDDuration624000JPY
Deferred gains or losses on hedges net of tax ociCurrentYTDDuration-32000JPY
Foreign currency translation adjustment net of tax ociPrior1YTDDuration19462000JPY
Foreign currency translation adjustment net of tax ociCurrentYTDDuration89352000JPY
Remeasurements of defined benefit plans net of tax ociPrior1YTDDuration-6033000JPY
Remeasurements of defined benefit plans net of tax ociCurrentYTDDuration-8779000JPY
Share of other comprehensive income of associates accounted for using equity method ociPrior1YTDDuration-447000JPY
Share of other comprehensive income of associates accounted for using equity method ociCurrentYTDDuration81000JPY
Other comprehensive incomePrior1YTDDuration151083000JPY
Other comprehensive incomeCurrentYTDDuration146527000JPY
Comprehensive incomePrior1YTDDuration1281318000JPY
Comprehensive incomeCurrentYTDDuration747545000JPY
Comprehensive income attributable to owners of the parentPrior1YTDDuration1281318000JPY
Comprehensive income attributable to owners of the parentCurrentYTDDuration752578000JPY
Comprehensive income attributable to non controlling interestsPrior1YTDDuration－JPY
Comprehensive income attributable to non controlling interestsCurrentYTDDuration-5033000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q3r_E02585-000FineChemicalsReportableSegmentsMember16950804000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q3r_E02585-000HealthAndBeautyCareFoodReportableSegmentsMember20849269000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q3r_E02585-000MedicalReportableSegmentsMember9691566000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q3r_E02585-000IndustrialChemicalsReportableSegmentsMember6235931000JPY
Revenues from external customersPrior1YTDDuration_ReportableSegmentsMember53727572000JPY
Revenues from external customersPrior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember－JPY
Revenues from external customersPrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember53727572000JPY
Revenues from external customersPrior1YTDDuration_ReconcilingItemsMember36000JPY
Revenues from external customersPrior1YTDDuration53727608000JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q3r_E02585-000FineChemicalsReportableSegmentsMember669479000JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q3r_E02585-000HealthAndBeautyCareFoodReportableSegmentsMember29030000JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q3r_E02585-000MedicalReportableSegmentsMember231946000JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q3r_E02585-000IndustrialChemicalsReportableSegmentsMember44708000JPY
Transactions with other segmentsPrior1YTDDuration_ReportableSegmentsMember975165000JPY
Transactions with other segmentsPrior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember－JPY
Transactions with other segmentsPrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember975165000JPY
Transactions with other segmentsPrior1YTDDuration_ReconcilingItemsMember-975165000JPY
Transactions with other segmentsPrior1YTDDuration－JPY
Net salesPrior1YTDDuration_jpcrp040300-q3r_E02585-000FineChemicalsReportableSegmentsMember17620283000JPY
Net salesPrior1YTDDuration_jpcrp040300-q3r_E02585-000HealthAndBeautyCareFoodReportableSegmentsMember20878300000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2021-11-30pass rounding
balance sheet identityconsolidated 2022-08-31pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2021-11-30pass
statement vs summary · net assetsconsolidated 2022-08-31pass
statement vs summary · net income attributable to parentconsolidated 2020-12-01/2021-08-31pass
statement vs summary · net income attributable to parentconsolidated 2021-12-01/2022-08-31pass
statement vs summary · revenueconsolidated 2020-12-01/2021-08-31pass
statement vs summary · revenueconsolidated 2021-12-01/2022-08-31pass
statement vs summary · total assetsconsolidated 2021-11-30pass
statement vs summary · total assetsconsolidated 2022-08-31pass